Seegene Stock Current Asset

096530 Stock  KRW 23,150  50.00  0.22%   
Seegene fundamentals help investors to digest information that contributes to Seegene's financial success or failures. It also enables traders to predict the movement of Seegene Stock. The fundamental analysis module provides a way to measure Seegene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Seegene stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Seegene Company Current Asset Analysis

Seegene's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Current Asset

 = 

Cash

+

Deposits

+

Liquid Assets

More About Current Asset | All Equity Analysis

Current Seegene Current Asset

    
  151.8 B  
Most of Seegene's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seegene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition

In accordance with the recently published financial statements, Seegene has a Current Asset of 151.8 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current asset for all Republic of Korea stocks is notably lower than that of the firm.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Seegene Fundamentals

About Seegene Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Seegene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seegene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seegene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Other Information on Investing in Seegene Stock

Seegene financial ratios help investors to determine whether Seegene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seegene with respect to the benefits of owning Seegene security.